Chemed Corp (CHE)
614.68
-3.88 (-0.63%)
NYSE · Last Trade: Apr 3rd, 1:53 AM EDT
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the senior health, home health & hospice industry, including Brookdale (NYSE:BKD) and its peers.
Via StockStory · April 2, 2025
Via Benzinga · March 25, 2025
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns -
over the past six months, healthcare stocks have collectively shed 9.4%. This performance was disappointing since the S&P 500 held its ground.
Via StockStory · March 18, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including AdaptHealth (NASDAQ:AHCO) and its peers.
Via StockStory · March 12, 2025

Via Benzinga · March 5, 2025

Via Benzinga · February 25, 2025

Healthcare services company Chemed Corporation (NYSE:CHE) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 9.2% year on year to $640 million. Its non-GAAP profit of $6.83 per share was 0.7% above analysts’ consensus estimates.
Via StockStory · February 26, 2025

Healthcare services company Chemed Corporation (NYSE:CHE)
will be reporting results tomorrow after market hours. Here’s what to expect.
Via StockStory · February 25, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how AdaptHealth (NASDAQ:AHCO) and the rest of the senior health, home health & hospice stocks fared in Q3.
Via StockStory · February 14, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Brookdale (NYSE:BKD) and its peers.
Via StockStory · February 14, 2025

Via Benzinga · February 6, 2025

Via Benzinga · January 20, 2025

Via Benzinga · January 9, 2025

Looking back on senior health, home health & hospice stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Chemed (NYSE:CHE) and its peers.
Via StockStory · February 14, 2025

Let’s dig into the relative performance of The Pennant Group (NASDAQ:PNTG) and its peers as we unravel the now-completed Q3 senior health, home health & hospice earnings season.
Via StockStory · February 13, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Option Care Health (NASDAQ:OPCH) and its peers.
Via StockStory · February 13, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at senior health, home health & hospice stocks, starting with BrightSpring Health Services (NASDAQ:BTSG).
Via StockStory · February 11, 2025

Via Benzinga · December 16, 2024

As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including Addus HomeCare (NASDAQ:ADUS) and its peers.
Via StockStory · February 11, 2025

Via Benzinga · October 25, 2024

Via Benzinga · October 21, 2024